Application Nr Approved Date Route Status External Links
ANDA083329 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage For The Treatment Of Schizophrenia; To Control Nausea And Vomiting; For Relief Of Restlessness And Apprehension Before Surgery; For Acute Intermittent Porphyria; As An Adjunct In The Treatment Of Tetanus; To Control The Manifestations Of The Manic Type Of Manic-Depressive Illness; For Relief Of Intractable Hiccups; For The Treatment Of Severe Behavioral Problems In Children (1 To 12 Years Of Age) Marked By Combativeness And/or Explosive Hyperexcitable Behavior (Out Of Proportion To Immediate Provocations), And In The Short-Term Treatment Of Hyperactive Children Who Show Excessive Motor Activity With Accompanying Conduct Disorders Consisting Of Some Or All Of The Following Symptoms: Impulsivity, Difficulty Sustaining Attention, Aggressivity, Mood Lability, And Poor Frustration Tolerance.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Chlorpromazine Hydrochloride CHLORPROMAZINE HYDROCHLORIDE ZINC44027

Comments